Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.
Atherosclerosis, a chronic inflammatory lipid storage disease of large arteries, is complicated by cardiovascular events usually precipitated by plaque rupture or erosion. Inflammation participates in lesion progression and plaque rupture. Identification of leukocyte populations involved in plaque destabilization is important for effective prevention of cardiovascular events. This study investigates CD1d-expressing cells and invariant NKT cells (iNKT) in human arterial tissue, their correlation with disease severity and symptoms, and potential mechanisms for their involvement in plaque formation and/or destabilization. CD1d-expressing cells were present in advanced plaques in patients who suffered from cardiovascular events in the past and were most abundant in plaques with ectopic neovascularization. Confocal microscopy detected iNKT cells in plaques, and plaque-derived iNKT cell lines promptly produced proinflammatory cytokines when stimulated by CD1d-expressing APC-presenting α-galactosylceramide lipid antigen. Furthermore, iNKT cells were diminished in the circulating blood of patients with symptomatic atherosclerosis. Activated iNKT cell-derived culture supernatants showed angiogenic activity in a human microvascular endothelial cell line HMEC-1-spheroid model of in vitro angiogenesis and strongly activated human microvascular endothelial cell line HMEC-1 migration. This functional activity was ascribed to IL-8 released by iNKT cells upon lipid recognition. These findings introduce iNKT cells as novel cellular candidates promoting plaque neovascularization and destabilization in human atherosclerosis.
Laboratory for Signal Transduction, Department of Biomedicine, Basel University Hospital, Basel, Switzerland.
Emmanouil
E
Kyriakakis
Marco
M
Cavallari
Jan
J
Andert
Maria
M
Philippova
Christoph
C
Koella
Valery
V
Bochkov
Paul
P
Erne
S Brian
SB
Wilson
Lucia
L
Mori
Barbara C
BC
Biedermann
Therese J
TJ
Resink
Gennaro
G
De Libero
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D055610:Antigens, CD1d / Q000096:biosynthesis / Q000276:immunology; D001158:Arteries / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D050197:Atherosclerosis / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D002460:Cell Line; D002465:Cell Movement / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis / Q000276:immunology; D042783:Endothelial Cells / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D005260:Female; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D018836:Inflammation Mediators / Q000276:immunology / Q000378:metabolism; D008297:Male; D055611:Natural Killer T-Cells / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000276:immunology* / Q000378:metabolism / Q000473:pathology
D055610:Antigens, CD1d; C526877:CD1D protein, human; D016207:Cytokines; D018836:Inflammation Mediators